Table 1:
Site of amputation | Dosage (mg/kg) | Total number of limbs amputated | Total number of limbs evaluatedβ | Regenerates exhibiting*¥ | ||||
---|---|---|---|---|---|---|---|---|
Carpal fusions | Carpal duplications | Cartilage nodules** | Autopods with a reduced number of digits | Normal limbs | ||||
Proximal | 0 (vehicle treated) | 14 | 14 | 1 (7.14%) | 3 (21.43%) | 3 (21.43%) | 0 | 8 (57.14%) |
1 | 10 | 10 | 2 (20%) | 1 (10%) | 4 (40%) | 0 | 4 (40%) | |
10 | 10 | 8 | 6 (75%) | 0 | 2 (25%) | 0 | 2 (25%) | |
Distal | 0 (vehicle treated) | 9 | 7 | 5 (71.43%) | 0 | 1 (14.29%) | 1 (11.11%) | 1 (11.11%) |
1 | 10 | 10 | 7 (70%) | 0 | 5 (50%) | 3 (30%) | 0 | |
10 | 10 | 10 | 10 (100%) | 0 | 8 (80%) | 2 (20%) | 0 |
# of regenerated limbs exhibiting a specific phenotype. The % of total regenerates is provided in parentheses
At the site of amputation
Some limbs exhibited multiple abnormalities
A small number of animal deaths and the failure of limbs to regenerate reduced the number of limbs that were ultimately evaluated between experimental groups